cystinosis

In a report published Monday, Wedbush analysts David M. Nierengarten, Ph.D., and Dilip Joseph previewed fourth quarter earnings for Raptor Pharmaceutical Corp. (NASDAQ: RPTP), “lowering sales estimates with US market saturation and slow EU launch.” The specialists reiterated an...